Peter Dutton

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT3VIN): a multicentre, open-label, randomised, phase 2 trial

Amanda Tristram, Tracie Madden, Ned Powell et al. · The Lancet Oncology · 2014 · 106 citations · Full text

Medicine, Dermatology, Surgery +15

Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial

Sally Hopewell, Isabelle Boutron, Douglas G. Altman et al. · BMC Medicine · 2016 · 70 citations · Full text

Pharmacy, Biostatistics, Clinical Epidemiology +14

Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials—ESORT)

Ayodele Odutayo, Connor A. Emdin, Allan J. Hsiao et al. · BMJ · 2017 · 51 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

Health-Related Quality of Life in SCALOP, a Randomized Phase 2 Trial Comparing Chemoradiation Therapy Regimens in Locally Advanced Pancreatic Cancer

Somnath Mukherjee, John Bridgewater, Stephen Falk et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 41 citations · Full text

Medicine, Oncology, Radiation Oncology +17